Hospital AI Lab HOSPITAL AI LAB — 醫療 AI 的實務資訊

更新日期:

臺灣的醫療技術與學術論文

臺灣的醫師與研究人員現在發表了什麼、正在試驗什麼?本頁只收錄近一年內、作者單位含臺灣的論文,以及在臺灣設有試驗地點的藥物試驗,分成手術技術、新藥與療法、疾病三類。

期間:2025-11-16 至 2026-11-16 · 每週自動更新

如何閱讀本頁
  • 這是從 PubMed 與 ClinicalTrials.gov 自動彙整的標題、期刊、日期與連結清單。本站不轉載摘要或內文,也未查證研究結果。
  • 有論文或試驗,並不代表該療法有效或安全,也不是醫療建議。任何治療請務必與您的醫療人員討論。
  • 「臺灣論文」指作者單位至少有一處含臺灣,不代表整項研究都在臺灣進行。
  • 標題以原文(多為英文)顯示。

手術技術

微創、機器人輔助、內視鏡、人工關節與移植等手術方法的論文

符合 697 筆,顯示最新 12 筆

  1. Good outcome can be achieved by femoral neck system with a supplementary Pauwels screw for unstable Pauwels type III femoral neck fractures in less than 65 years old adults

    Eur J Orthop Surg Traumatol 2026-11-14 Wu CY, Chen CY, Lin KC PMID 43033279

  2. Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications

    Biomed Mater Eng 2026-11-13 Wu CC, Yeh L, Chiang CY et al. PMID 43023403

  3. Trapezium-sparing distraction arthroplasty using the abductor pollicis longus tendon for advanced trapeziometacarpal osteoarthritis: A retrospective case series

    J Orthop Sci 2026-11-10 Lee CY, Huang HK, Yen CY et al. PMID 43009348

  4. Risk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia

    Transplant Cell Ther 2026-11-06 Tsai XC, Liu JH, Hsiao LT et al. PMID 42994757

  5. Population pharmacokinetic models for unbound mycophenolic acid

    Expert Opin Drug Metab Toxicol 2026-11-06 Rong Y, Chang ST, Chen SH et al. PMID 42912473

  6. Real-World Comparison of Cardiorenal Outcomes With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Type 2 Diabetes

    Diabetes Obes Metab 2026-11-02 Huang CH, Wu JL, Ling TC et al. PMID 42972883

  7. Sng as a distinct pain phenotype after minimally invasive spine surgery: Implications for analgesic use and recovery outcomes

    J Formos Med Assoc 2026-11-02 Trinh DT, Lin JY, Chen LY et al. PMID 42967846

  8. Thoracic Endometriosis Mimicking a Lung Mass: Management With Single-Stage Biopsy and Microwave Ablation

    Respirol Case Rep 2026-11-01 Hsieh M, Yang SM, Huang HN PMID 42978679

  9. Extracorporeal photopheresis for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation: A systematic review

    Respir Med 2026-11-01 Jaing TH, Wang YL, Lee WJ et al. PMID 42977039

  10. Accuracy of robotic systems in dental implant placement with clinical subgroup analyses: A systematic review and meta-analysis

    Jpn Dent Sci Rev 2026-10-01 Linn TY, Ashry A, Abbas H et al. PMID 42866607

  11. Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial

    Metabolism 2026-09-29 Yen FS, Liao PL, Hung YM et al. PMID 42810614

  12. Erector spinae plane block within ERAS protocols reduces analgesic requirements in aged, high-risk patients after MIS-TLIF: a propensity score-matched analysis

    N Am Spine Soc J 2026-09-10 Chen LY, Lin JY, Tu YT et al. PMID 42991997

新藥與療法(論文)

藥物、抗體、疫苗與新療法的第一至三期及隨機對照試驗論文

符合 220 筆,顯示最新 12 筆

  1. A pilot study of electromagnetic therapy versus biofeedback-based pelvic floor muscle training for pelvic organ prolapse: A mixed-methods approach

    Taiwan J Obstet Gynecol 2026-11-01 Lin KY, Wang LY, Wu PC et al. PMID 42951461

  2. First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial

    Lancet 2026-10-26 Slomovitz BM, Zhu J, Yin R et al. PMID 42933458

  3. TRANSFORM-1 phase 3 study: efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis

    Blood 2026-10-15 Pemmaraju N, Mead AJ, Somervaille TCP et al. PMID 42378247

  4. Phase 1 study of OX40 agonist ABBV-368 as monotherapy or in combination with budigalimab in advanced solid tumors

    Future Oncol 2026-10-01 Oliva M, Powderly J, Le Tourneau C et al. PMID 42956185

  5. Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial

    Lancet Haematol 2026-10-01 He H, Shang J, Wang Y et al. PMID 42822478

  6. [Effectiveness of a Multimodal Nursing Intervention for Primary Caregivers in Preventing Medical Adhesive-Related Skin Injury]

    Hu Li Za Zhi 2026-10-01 Chou SH, Gau YM, Chang CH PMID 42772911

  7. Outcomes of Mirror Therapy Preceding Augmented Reality in Stroke Rehabilitation: A Randomized Controlled Trial

    Am J Occup Ther 2026-09-22 Lin CJ, Lin KC, Chen MH et al. PMID 42770516

  8. Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial

    Lancet Oncol 2026-09-07 Vergote I, Cibula D, Powell M et al. PMID 42705254

  9. Effectiveness of a school-based multicomponent intervention on parental HPV knowledge, vaccination attitudes, and children's HPV vaccine completion: A mixed-methods cluster randomized controlled trial

    Patient Educ Couns 2026-09-06 Sandi YDL, Wu LM, Andarini E et al. PMID 42748641

  10. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

    N Engl J Med 2026-08-29 Gibson CM, Steg PG, Bahit MC et al. PMID 42670965

  11. Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial

    Ann Oncol 2026-08-24 Garber JE, Cameron D, Campbell C et al. PMID 42636977

  12. Atezolizumab with or without tiragolumab in unresectable esophageal squamous-cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study

    Ann Oncol 2026-08-21 Xu RH, Cho BC, Chen M et al. PMID 42628839

近一年開始的藥物試驗

登錄於 ClinicalTrials.gov、在臺灣設有試驗地點的藥物試驗(由新到舊)

符合 261 筆,顯示最新 12 筆

  1. A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both

    NCT07931599 期別: Phase 3 開始日期: 2026-11-10 主辦單位: Novo Nordisk A/S 疾病: Diabetes Mellitus, Type 2 藥物/介入: Zenagamtide, Semaglutide

  2. An Exploratory Study of Single-Dose Neoadjuvant Nivolumab Without Surgical Delay in Patients With Resectable HCC

    NCT07902258 期別: Phase 2 開始日期: 2026-11-02 主辦單位: National Taiwan University Hospital 疾病: Hepato Cellular Carcinoma (HCC), Immune Checkpoint Inhibitor, Neoadjuvant Therapy 藥物/介入: Nivolumab

  3. A Phase 1, Open-Label, Two-Stage, Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of EI-1071 Under Fasted or Fed Conditions in Healthy Volunteers

    NCT07903337 期別: Phase 1 開始日期: 2026-11-01 主辦單位: Elixiron Immunotherapeutics Inc. 疾病: Food Effect in Healthy Volunteers 藥物/介入: EI-1071

  4. Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

    NCT07513623 期別: Phase 2 開始日期: 2026-11-01 主辦單位: University of California, San Francisco 疾病: Cytomegalovirus (CMV), Anterior Uveitis, Infectious Uveitis 藥物/介入: Valganciclovir, Ganciclovir (GCV)

  5. Effect of Probiotic Nasal Irrigation on the Postoperative Care of Chronic Rhinosinusitis

    NCT07865715 期別: N/A 開始日期: 2026-10-31 主辦單位: Taichung Veterans General Hospital 疾病: Sinusitis Chronic, Postoperative Care 藥物/介入: heat-killed probiotic LDL557 (Lactobacillus delbrueckii subsp. lactis LDL557), Normal Saline (NS)

  6. A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055)

    NCT07829783 期別: Phase 3 開始日期: 2026-10-23 主辦單位: Merck Sharp & Dohme LLC 疾病: Bladder Cancer 藥物/介入: Sac-TMT, Pembrolizumab and Berahyaluronidase alfa

  7. A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis

    NCT07914088 期別: Phase 2 開始日期: 2026-10-21 主辦單位: Arjil Pharmaceuticals LLC 疾病: Dermatitis Atopic 藥物/介入: 0.5% AR100DP1, Placebo

  8. A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

    NCT07881458 期別: Phase 3 開始日期: 2026-10-16 主辦單位: Eli Lilly and Company 疾病: Obesity, Overweight, Diabetes Mellitus, Type 2 藥物/介入: eloralintide and tirzepatide, Tirzepatide

  9. A Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]

    NCT07890714 期別: Phase 1 / Phase 2 開始日期: 2026-10-16 主辦單位: Daiichi Sankyo 疾病: Urothelial Cancer, Non-small Cell Lung Cancer 藥物/介入: Dato-DXd, Enfortumab Vedotin (EV)

  10. Comparison of HPI-guided Norepinephrine Boluses, ClearSight-guided Norepinephrine Infusion, and Oscillometric-guided Norepinephrine Infusion for Blood Pressure Stability During Cesarean Delivery

    NCT07883265 期別: N/A 開始日期: 2026-10-15 主辦單位: National Taiwan University Hospital 疾病: Hypotension During Cesarean Delivery, Blood Pressure Monitoring 藥物/介入: Hypotension Prediction Index derived from the noninvasive arterial waveform, Continuous noninvasive arterial pressure monitoring (HPI blinded)

  11. Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

    NCT07578649 期別: Phase 3 開始日期: 2026-10-14 主辦單位: Pfizer 疾病: Endometrial Neoplasms, Endometrial Cancer 藥物/介入: PF-08634404, Pembrolizumab

  12. A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)

    NCT07700758 期別: Phase 2 開始日期: 2026-10-13 主辦單位: Merck Sharp & Dohme LLC 疾病: Malignant Neoplasm 藥物/介入: Belzutifan

疾病與族群研究

全國性世代、登錄資料與族群研究所呈現的發生率與盛行率

符合 2,501 筆,顯示最新 12 筆

  1. Nationwide clinical-genomic epidemiology of listeriosis in Taiwan, 2018-2025: disease manifestations in relation to clonal background

    Emerg Microbes Infect 2026-11-14 Chiou CS, Wang KC, Chang JH et al. PMID 42986129

  2. Community gun violence and social isolation: A neighborhood analysis in forty U.S. States

    Soc Sci Med 2026-11-04 Lu YF, Semenza DC PMID 42994346

  3. Safety profiles of tocilizumab and tofacitinib in rheumatoid arthritis: a propensity score-weighted comparative analysis

    Clin Rheumatol 2026-10-26 Tsai PH, Chen YF, Fang YF PMID 42932088

  4. Factors contributing to workplace violence against nurses perpetrated by patients or visitors (type II violence) in the United States: A scoping review

    Int J Nurs Stud Adv 2026-10-21 Tessmer L, Chang YC, Yaeger L PMID 42992215

  5. Prevalence and Impact of Popliteal Artery Injury Associated with Knee Dislocations, Ligament Injuries, and Peri-Knee Fractures: Analysis of the Nationwide Readmission Database, 2016-2020

    J Invest Surg 2026-10-21 Teng HG PMID 42905570

  6. Age 70 as a threshold for vulnerable road user case fatality: A population-based study of older drivers in Taiwan

    Accid Anal Prev 2026-10-15 Widodo AF, Chan CW, Rohmah I et al. PMID 42879899

  7. Clinical outcomes of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and acute heart failure: a multi-institutional study

    Ann Med 2026-10-11 Huang B, Chen CC, Tsai ML et al. PMID 42860551

  8. Bridging the intention‒behavior gap in herpes zoster vaccination: A nationwide survey in a self-payment setting

    Hum Vaccin Immunother 2026-10-07 Liou FY, Chen CY, Chang YF et al. PMID 42842236

  9. Global Landscape of Clinical Studies Open to Enrollment in Carbon Ion Radiotherapy: A PTCOG Review

    Int J Part Ther 2026-10-06 Holtzman AL, Giap H, Ishikawa H et al. PMID 42893060

  10. Dyslipidemia and risk of osteonecrosis of the femoral head: A large-scale propensity score-matched cohort study

    Bone 2026-09-28 Nguyen DT, Nguyen NTB, Wu LC et al. PMID 42805283

  11. Nationwide characterization of microplastics in sewage sludge as a baseline for sludge quality assessment and valorization planning

    Waste Manag 2026-09-26 Abada Robby MD, Jachimowicz P, Solayman HM et al. PMID 42801818

  12. Differential patterns of postpartum depression following vaginal and caesarean births: The moderating role of emotional support

    Midwifery 2026-09-26 Chiu HY, Chen HH, Wang CW et al. PMID 42822074

出處: PubMed · ClinicalTrials.gov